Entry |
|
Name |
Interferon alfa (NAMALWA) (JP18); Interferon alfa (BALL-1) (JAN); Interferon alfa (INN); OIF (TN) |
Class |
Immunological agent
DG01752 Interferone
|
Remark |
Therapeutic category: | 6399 |
Product (DG01750): | D03305<JP> |
|
Efficacy |
Antineoplastic, Antiviral, Biological response modifier |
Target |
|
Pathway |
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04620 | Toll-like receptor signaling pathway |
hsa04650 | Natural killer cell mediated cytotoxicity |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB01 Interferon alfa natural
D03305 Interferon alfa (NAMALWA) (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
639 Miscellaneous
6399 Others
D03305 Interferon alfa (NAMALWA) (JP18); Interferon alfa (BALL-1) (JAN); Interferon alfa (INN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01750 Interferon alpha
D03305 Interferon alfa (NAMALWA)
Drug classes [BR:br08332]
Immunological agent
DG01752 Interferone
D03305 Interferon alfa (NAMALWA)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D03305 Interferon alfa (NAMALWA) (JP18) <JP>
IFNAR2
D03305 Interferon alfa (NAMALWA) (JP18) <JP>
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D03305 Interferon alfa (NAMALWA) (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03305 Interferon alfa (NAMALWA)
D03305 Interferon alfa (NAMALWA) injection
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01750 Interferon alpha
Antimicrobials abbreviations [BR:br08327]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
DG01750 Interferon alpha
|
Other DBs |
|
LinkDB |
|